Events

Philips Intellivue Patient Monitor X3 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Philips Electronics Australia Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2017-RN-01518-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2017-12-19
  • 사례 국가
    Australia
  • 사례 출처
    DHTGA
  • 사례 출처 URL
    https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2017-RN-01518-1
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Philips has discovered that the nbp measurement of x3 intermittently displays only mean values instead of the diastolic and systolic blood pressure values. furthermore, occasionally the monitor shows the ‘check touch input” message, indicating that the touchscreen controls may not function.
  • 조치
    Philips will distribute a software update for the affected devices and replace the display assembly. Philips has provided a workaround until the corrections are implemented. Users should consider using an alternative monitor in situations where the touchscreen controls are needed when using the X3 in standalone mode.

Device

Philips Intellivue Patient Monitor X3

Manufacturer

Philips Electronics Australia Ltd
  • 제조사 모회사 (2017)
    Philips
  • Source
    DHTGA